Robert E. Hoffman - 02 Jan 2025 Form 4 Insider Report for TuHURA Biosciences, Inc./NV (HURA)

Reporting relationship: Director
Issuer ticker: HURA
Reported as of: 02 Jan 2025
Net transaction value: $0
SEC form: 4
Accepted by SEC: 06 Jan 2025, 17:08:15 UTC
Prior SEC filing: 27 Aug 2024
Next SEC filing: 02 Apr 2025
Source filing: View source filing
Reporting owner signature: /s/ Robert E. Hoffman

Key filing fact

Robert E. Hoffman filed Form 4 for TuHURA Biosciences, Inc./NV (HURA) on 06 Jan 2025.

Key facts

This page summarizes Robert E. Hoffman's Form 4 filing for TuHURA Biosciences, Inc./NV (HURA).
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 06 Jan 2025, 17:08.

Change

Previous filing in this sequence was filed on 27 Aug 2024.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

HURA transaction Derivative

Options (Right to Buy)

Award

Transaction value: $0
Shares: +51,275
Change %
Price: $0.000000
Shares after: 51,275
Date: 02 Jan 2025
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 51,275
Exercise price: $4.11
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Represents an annual option grant under the TuHURA Biosciences, Inc. Non-Employee Director Compensation Program. One-third of the stock options become exercisable on the first, second, and third anniversaries of January 2, 2025.